← Eichor
Study identifier: NCT06255886 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Treatment of Gastroesophageal Reflux Disease in Infants

Condition: Gastroesophageal Reflux · Infant, Newborn, Diseases  ·  Sponsor: Odense University Hospital

PhasePhase 4
Planned participants96
Who can joinAll sexes, 1 Month to 1 Year
Healthy volunteersNo

About this study

Gastroesophageal reflux disease in infants is not fully understood. Infants are prescribed medical treatments that may not be effective or that contribute to adverse side effects and lead to concerns and expenses for the parents and healthcare system. Current guidelines recommend cow-milk-protein free diet as a first-line treatment, but these recommendations are based on weak evidence. This study investigate the efficacy of a cow-milk-protein free diet compared to treatment with a proton pump inhibitor (omeprazole)

This description comes directly from the study's public registry record.

Talk to the study team

Natalia K Barkholt, MD  ·  +4521787136  ·  Natalia.Barkholt@rsyd.dk

Gitte Zachariassen, Professor  ·  +4565413809  ·  Gitte.Zachariassen@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (3)

Paediatric Department, Hospital of Southern JutlandAabenraa, Region Syddanmark, DenmarkRecruiting
Børnelægecentret v/Kasper DalbyOdense, Region Syddanmark, DenmarkNot Yet Recruiting
H.C Andersen Childrens' HospitalOdense, Region Syddanmark, DenmarkNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06255886